Provenance du réseau au premier degré de Malin Hultqvist Hopkins
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden.
3
| Holding Company | Medical Specialties | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Malin Hultqvist Hopkins via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Lund | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Stockholm | College/University | Corporate Officer/Principal | |
Glucox Biotech AB
 Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Karolinska Institutet | College/University | Corporate Officer/Principal | |
| University of Turku | College/University | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Masters Business Admin | |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Suède | 9 |
| Etats-Unis | 2 |
| Finlande | 2 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 4 |
| Commercial Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 9 |
| Director/Board Member | 6 |
| Chief Executive Officer | 3 |
| Founder | 2 |
| Chairman | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Malin Hultqvist Hopkins
- Connexions Sociétés
